SA
Sign upLog In

RIGL R&D Expenses

Rigel Pharmaceuticals Inc · R&D Expenses

RIGL logo

RIGL R&D Expenses

Latest reported$13.96M
RIGL Quarterly R&D Expenses ($0.00 → $13.96M)
High-resolution chart · PNG

RIGL r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Rigel Pharmaceuticals Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
13,961,000
11,676,000
10,685,000
7,353,000
6,821,000
8,436,000
5,632,000
6,182,000
5,540,000
6,026,000
3,186,000
6,475,000
4,772,000
10,089,000
15,365,000
14,666,000
14,767,000
15,474,000
13,304,000
18,300,000
16,807,000
16,826,000
15,138,000
14,600,000
14,214,000
16,149,000
14,247,000
14,463,000
13,226,000
10,949,000
13,767,000
11,097,000
10,797,000
11,242,000
11,561,000
10,808,000
11,524,000
12,376,000
11,634,000
16,171,000
17,468,000
18,173,000
16,563,000
15,501,000
15,059,000
15,702,000
14,613,000
16,151,000
20,063,000
16,869,000
18,046,000
17,574,000
19,393,000
20,315,000
19,764,000
20,186,000
20,924,000
17,904,000
19,819,000
17,316,000
17,109,000
15,106,000
13,758,000
16,394,000
16,815,000
17,425,000
20,175,000
21,082,000
24,948,000
24,538,000
28,402,000
31,232,000
28,416,000
21,620,000
21,960,000
15,372,000
17,189,000
15,843,000
15,002,000
14,050,000
13,205,000
14,711,000
13,382,000
13,676,000
13,807,000
11,173,000
12,295,000
13,266,000
11,268,000
11,694,000
11,666,000
10,989,000
10,698,000
10,010,000
9,569,000
11,624,000
12,066,000
10,091,000
8,918,000
8,631,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.